Clinical activity of lorlatinib in patients with ROS1+ advanced non-small cell lung cancer: Phase 2 study cohort EXP-6 Meeting Abstract
| Authors: | Ou, S.; Shaw, A.; Riely, G.; Chiari, R.; Bauman, J.; Clancy, J.; Thurm, H.; Peltz, G.; Abbattista, A.; Solomon, B. |
| Abstract Title: | Clinical activity of lorlatinib in patients with ROS1+ advanced non-small cell lung cancer: Phase 2 study cohort EXP-6 |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | nsclc; ros1; lorlatinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S322 |
| End Page: | S323 |
| Language: | English |
| ACCESSION: | WOS:000454014500225 |
| DOI: | 10.1016/j.jtho.2018.08.241 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA02.03 -- Source: Wos |
